ISSN: 2164-5515

Journal Home

Journal Guideline

Human Vaccines and Immunotherapeutics Q2 Unclaimed

Landes Bioscience United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human Vaccines and Immunotherapeutics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 103. It has an SJR impact factor of 0,897 and it has a best quartile of Q2. It has an SJR impact factor of 0,897.

Human Vaccines and Immunotherapeutics focuses its scope in these topics and keywords: vaccination, vaccine, immune, antibody, awareness, children, hpv, neutralizing, rotavirus, vaccines, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2) Medicine (miscellaneous) (Q2) Pharmacology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,897

SJR Impact factor

103

H Index

534

Total Docs (Last Year)

1905

Total Docs (3 years)

23691

Total Refs

6308

Total Cites (3 years)

1666

Citable Docs (3 years)

3.29

Cites/Doc (2 years)

44.37

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
British Journal of Nutrition Q2
Neurodegenerative disease management Q2

Compare this journals

Aims and Scope

Best articles by citations

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

Epidemiological characterizations, pathogen spectrum and molecular characteristics of Coxsackievirus A16 from patients with HFMD in Yantai, Shandong, China between 2011 and 2015

H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance

Hyperimmune bovine colostrum for treatment of GI infections

An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice

Letter from the Editor

Consumer reporting of adverse events following immunization

Acceptability of meningococcal serogroup B vaccine among parents and health care workers in Italy: A survey

Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults

Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism

Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line

SHOW MORE ARTICLES

Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

Current opinion and review on peanut oral immunotherapy

Influenza immunization of chronically ill children in pediatric tertiary care hospitals

Review of DNA tumour viruses

Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site

Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology

Challenges and changes: Immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response

Influenza vaccination in health-care workers: an evaluation of an on-site vaccination strategy to increase vaccination uptake in HCWs of a South Italy Hospital

Tecemotide: An antigen-specific cancer immunotherapy

Development of improved pertussis vaccine

The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine